Navigation Links
MiMedx Completes Acquisition of Surgical Biologics
Date:1/5/2011

y commercialize our technologies.  HydroFix™ and CollaFix™ are trademarks of MiMedx Group, Inc.

Safe Harbor Statement

This press release includes statements that look forward in time or that express management's beliefs, expectations or hopes.  Such statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements include, but are not limited to, the potential synergies between Surgical Biologics' technologies and MiMedx' current product technologies, the potential product opportunities and the expectations for Surgical Biologics revenues for 2011. These statements are based on current information and belief, and are not guarantees of future performance.  Among the risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements include that  the anticipated therapeutic benefits  may not be achieved, that the uses for and physician utilization of the  Purion® technology platform do not meet expectations, that the Company may not receive requisite regulatory clearances and/or approvals to be able to develop and market its full range of potential products from the Purion® technology platform or from its other proprietary technologies , or that such clearances or approvals may be delayed, that the Company does not  achieve the 2011 revenue expectations projected from the Surgical Biologics business, that the Company requires  significant additional capital to survive and achieve its goals, which may be difficult or impossible to obtain; that cost reductions may not be sustained or be sufficient to enable the Company to achieve profitability, that the Company may not be able to establish an effective distribution system for its products in the U.S. or abroad, that the Company's products may not gain the anticipated acceptance in the marketplace or
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device
2. MiMedx Group Announces CE Mark for the HydroFix(TM) Spine Shield
3. MiMedx Group Announces Addition of Sales Director for Europe
4. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
5. MiMedx Announces Agreement to Acquire Surgical Biologics
6. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 Velplex, LLC announced this week that ... that connects buyers and sellers of discount dental ... Why? It,s because the business leaders ... with the dental industry. They have 50 years of ... worked to negotiate some of the best prices in ...
(Date:6/17/2013)... HOUSTON , June 17, 2013 DNAtrix ... its CEO will present clinical data on the company,s ... meeting in Quebec City, Canada ... Tufaro , DNAtrix,s CEO and a leader in the ... a clinical study entitled A PHASE I TRIAL OF ...
(Date:6/17/2013)... ST. PAUL, Minn. , June 17, 2013 ... and branding and design agency, Larsen, was awarded the Silver ... Purpose, Repositioning Prime Therapeutics." The award was presented at the ... Awards Ceremony held June 13 at the AXA ... The Silver Anvil, which has been presented ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2
(Date:6/18/2013)... Lesbian, Gay, Bisexual and Transgender (LGBT) Pride ... sexual minority youth are still at greater ... according to the Suicide Prevention Resource Center. ... recently published recommendation to improve psychologists, treatment ... improve psychological functioning and reduce depression and ...
(Date:6/18/2013)... 2013)-- An international team of investigators co-led by Weill ... evidence-based surgery and device research, similar to the kind ... , "Currently, there is no dynamic research framework to ... benefits to patients or may even be harmful," says ... College. , In the June 18 issue of ...
(Date:6/18/2013)... FL (PRWEB) June 18, 2013 There ... best education for students around the country. Some of ... life is enriched by the areas or region. The ... the benefits of attending one of these hidden gems ... show informs viewers of the educational facilities with better ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Dr. Farooq ... the Atlanta Vision Institute, is pleased to announce that ... generation of Intralase LASIK equipment, the iFS™ Advanced Femtosecond ... LASIK practice in Atlanta to offer its patients this ... is giving his patients a complimentary upgrade to the ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... to protecting the rights of consumers, has filed a ... central air conditioner units from 2007 and onward under ... evaporator coils . The lawsuit was filed on May ... District of Florida (Case No. 8:13-cv-1213T17TBM). Goodman Global Inc., ...
Breaking Medicine News(10 mins):Health News:Sexual minority youth need specialized treatment from therapists 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3Health News:Editions TV Presents a Segment on the Higher Education Hidden Gems 2Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2Health News:Goodman and Amana Air Conditioners Allegedly Violated Consumer Warranties, Charges Class Action Lawsuit Filed by Parker Waichman LLP 2
... Coordinating and timing,activities is a top challenge that ... landmark clinical trials. Best-in-class,companies understand that successfully communicating ... findings are available. Successful,communication depends on early actions ... of breakthrough molecules in development -- Early ...
... UK and PHILADELPHIA, US June 17 ,Shire Limited ... today announced the publication of data from a,randomized, ... colitis (UC) drug Lialda(TM) (mesalamine). The primary endpoints,of ... tolerability of Lialda in,mild-to-moderate UC patients over 12 ...
... on octopuses has shed new light on how our ... of the Department of Neurobiology at the Alexander Silberman ... Jerusalem., Why octopuses?, Octopuses and other related creatures, known ... invertebrates because they have relatively large brains and they ...
... second it takes an ambulance to get to its ... driving faster, can ambulances get emergency services to people ... a classic operations research question that three Cornell researchers ... Foundation grant of almost $300,000 is allowing associate professor ...
... Europe,s position as a major player in genome ... Foundation,s three-year EUROCORES programme EuroDYNA. As it draws ... Chromatin Function) is leaving behind a healthy European ... the structure of the cellular nucleus and mechanisms ...
... tumor hypoglycemia (NICTH) is a rare association between ... than the pancreatic islets. It was initially associated ... types have been described. , The pathogenesis ... of mechanisms, including excessive consumption of glucose by ...
Cached Medicine News:Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 2Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 3Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 4Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 5Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 6Health News:Hebrew University research on octopuses sheds light on memory 2Health News:Hebrew University research on octopuses sheds light on memory 3Health News:Cornell efficiency experts seek to save precious minutes in deploying ambulances 2Health News:EuroDYNA leaves healthy genomic research ecosystem as legacy 2Health News:EuroDYNA leaves healthy genomic research ecosystem as legacy 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: